Amwill Health Care Limited (BOM:544353)

India · Delayed Price · Currency is INR

43.00

-1.48 (-3.33%)

At close: Sep 25, 2026

Market Cap	860.15M -27.1%
Revenue (ttm)	454.92M +12.1%
Net Income	114.21M +6.4%
EPS	5.71 -13.9%
Shares Out	20.00M
PE Ratio	7.53
Forward PE	n/a
Dividend	0.50 (1.16%)
Ex-Dividend Date	Aug 7, 2026

Volume	14,400
Open	43.01
Previous Close	44.48
Day's Range	43.00 - 43.05
52-Week Range	28.91 - 59.10
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 4, 2026

About Amwill Health Care

Amwill Health Care Limited, a derma-cosmetic company, engages in the development and contract manufacturing of generic dermatological solutions in India. It offers product formulations for anti-acne, dry skin, anti-aging, anti-fungal, anti-histaminic, anti-perspirant, antibiotics, skin lightening, hair care, steroid and keratolytic, sunscreen, vitiligo, miscellaneous, peri-orbital hyperpigmentation, anti-scar, topical antibiotics, antioxidants, and anti-scabies, as well as cosmeceutical and aesthetic categories. The company was founded in 2009 ... [Read more]

Industry Pharmaceutical Preparations

Founded 2009

Country India

Stock Exchange Bombay Stock Exchange

Ticker Symbol 544353

Full Company Profile

Financial Performance

In fiscal year 2026, Amwill Health Care's revenue was 454.92 million, an increase of 12.10% compared to the previous year's 405.82 million. Earnings were 114.21 million, an increase of 6.44%.

Financial Statements